The most frequent cancer types observed in carriers of TP53 pathogenic variants were breast cancer (24–31.2%), soft tissue and bone sarcoma (11.6–17.8%), followed by adrenocortical carcinoma (6.5–9.9%), and brain tumors ( 3.5–14%) [7, 10–13]. Here, TP53 is linked to breast cancer.